Last Updated:
Name Designation Appointment Date Status
Ajay Prem Juneja

Appointed as Director since March 2014

Director 01-Mar-2014 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Sapna Kulwant Kaushik

Appointed as Director since April 2022

Director 21-Apr-2022 Current

People Timeline

Explore the timeline of key personnel in Elis Pharmaceuticals (India) Private Limited's leadership journey.

Loading...
Contact Details
  • Address House No Wz-508/6 Kh No 1529 1St Floor, Blk-Wz Village Basai Darapur Landmark Near Govt School, New Delhi Delhi, 110015, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Elis Pharmaceuticals (India) Private Limited?
You can contact Elis Pharmaceuticals (India) Private Limited through their registered address at House No Wz-508/6 Kh No 1529 1St Floor, Blk-Wz Village Basai Darapur Landmark Near Govt School, New Delhi Delhi, 110015, India, or via their website at elispharma.org. Social media links are also provided where applicable.
Who are the current directors of Elis Pharmaceuticals (India) Private Limited?
The current directors of Elis Pharmaceuticals (India) Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SAPNA KULWANT KAUSHIK
  • AJAY PREM JUNEJA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available